SKI Market

A+| A| A-|

Indian Indices

Sensex

77,257.27 343.77
( 0.45%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

267.3488556

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

29.22

14830.69

EPS(TTM)

Face Value()

Div & Yield %

25.82

1.46

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	6032.63	5874.06	5149.00	5035.41	5066.89	4132.55
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	6032.63	5874.06	5149.00	5035.41	5066.89	4132.55
Other Income	60.75	504.88	3.54	51.14	83.90	134.75
Stock Adjustments	268.54	52.36	-72.84	-19.85	160.65	176.50
Total Income	6361.92	6431.30	5079.70	5066.70	5311.44	4443.80
EXPENDITURE :
Raw Materials	2057.31	1852.71	1587.29	1482.36	1464.67	1222.39
Power & Fuel Cost	179.67	173.32	151.19	120.50	118.31	97.43
Employee Cost	1466.57	1335.91	1094.82	1062.30	976.13	806.37
Other Manufacturing Expenses	388.12	327.87	357.21	324.10	344.44	291.44
Selling & Administrative Expenses	1269.90	1191.89	1173.00	1088.66	848.55	661.00
Miscellaneous Expenses	38.21	519.76	48.31	28.82	26.07	37.52
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	5399.78	5401.46	4411.82	4106.74	3778.17	3116.15
Operating Profit	962.14	1029.84	667.88	959.96	1533.27	1327.65
Interest	76.47	54.47	49.00	17.02	12.98	25.19
Gross Profit	885.67	975.37	618.88	942.94	1520.29	1302.46
Depreciation	277.08	271.14	272.95	284.93	182.55	135.67
Profit Before Tax	608.59	704.23	345.93	658.01	1337.74	1166.79
Tax	105.47	37.75	-0.80	114.46	241.20	197.39
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	503.12	666.48	346.73	543.55	1096.54	969.40
Extraordinary Items	14.19	0.99	0.05	2.81	5.20	-7.06
Adjusted Net Profit	488.93	665.49	346.68	540.74	1091.34	976.46
Adjustment below Net Profit	0.00	3494.43	0.00	-76.30	-114.90	-51.00
P & L Balance brought forward	4160.91	0.00	2632.89	2440.83	1709.19	1296.49
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	216.22	0.00	-672.07	275.19	250.00	525.97
P & L Balance carried down	4447.81	4160.91	3651.69	2632.89	2440.83	1688.92
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	550.00	550.00	400.00	500.00	700.00	500.00
Dividend Per Share(Rs)	11.00	11.00	8.00	10.00	14.00	10.00
Earnings Per Share-Unit Curr	25.60	33.91	17.64	27.65	55.79	51.43
Earnings Per Share(Adj)-Unit Curr	25.60	33.91	17.64	27.65	55.79	51.43
Book Value-Unit Curr	264.30	249.75	224.59	269.16	259.57	177.51
Book Value(Adj)-Unit Curr	264.30	249.75	224.59	269.16	259.57	177.51

77,257.27 343.77 ( 0.45%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)